| Status | Study |
| Not yet recruiting |
Study Name: Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition Condition: Iatrogenic Cushing's Disease Date: 2017-03-17 Interventions: Drug: AZD4017 and prednisolone |
| Completed |
Study Name: Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment Condition: Cushing Disease Date: 2017-03-03 Interventions: Drug: Pasireotide 0.6 MG/ML The aim of the study was to evaluate the effect of pasireotide on β -ce |
| Recruiting |
Study Name: Study to Evaluate CORT125134 in Patients With Cushing's Syndrome Condition: Cushing's Syndrome Date: 2016-06-15 Interventions: Drug: CORT125134 |
| Recruiting |
Study Name: Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors Condition: Pituitary Tumor ACTH-producing Pituitary Tumour Date: 2016-04-20 Interventions: Drug: Pasireotide LAR Pasireotide LAR (SIGNIFOR® LAR) |
| Recruiting |
Study Name: Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease Condition: Cushing's Disease Date: 2016-02-27 Interventions: Drug: osilodrostat In the form |
| Not yet recruiting |
Study Name: Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease Condition: Cushing's Disease Date: 2015-11-03 Interventions: Device: Virtual radial task in 3D The virtual radial task is a labyrinth in 3D with twelve ways. The pri |
| Recruiting |
Study Name: Cushing's Disease Complications Condition: Cushing's Disease Date: 2015-07-20 Interventions: Other: Exams and questionnaires Blood sample 24hrs urinary cortisol and salivary cortisol, urinary labst |
| Recruiting |
Study Name: Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease Condition: Cushing's Disease Corticotrophin Adenoma Date: 2015-06-21 Interventions: Drug: Gefitinib See Arm Description |
| Recruiting |
Study Name: Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome Condition: Cushing's Syndrome Ectopic Corticotropin Syndrome Adrenal Date: 2015-06-08 Interventions: Drug: Osilodrostat Osilodrostat will be prescribed by the investigator. Osirodrostat 1 mg, 5 mg, 10 mg, |
| Active, not recruiting |
Study Name: Cushing´s Disease Epidemiology in Sweden Condition: Cushing Disease Date: 2014-12-05 |